The clinical chemistry market size has grown strongly in recent years. It will grow from $16.06 billion in 2025 to $17.37 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to expansion of hospital laboratory infrastructure, rising prevalence of chronic diseases, increased utilization of routine blood and urine tests, growth of centralized diagnostic laboratories, improvements in biochemical assay technologies.
The clinical chemistry market size is expected to see strong growth in the next few years. It will grow to $23.57 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to growing demand for rapid diagnostic turnaround, rising adoption of decentralized testing models, expansion of personalized medicine diagnostics, increasing investments in automated laboratory solutions, higher focus on quality and compliance standards. Major trends in the forecast period include increasing adoption of fully automated chemistry analyzers, rising demand for high-throughput diagnostic testing, growing use of point-of-care chemistry systems, expansion of integrated analyzer-reagent platforms, enhanced focus on analytical accuracy and standardization.
The growing prevalence of chronic diseases is expected to drive the expansion of the clinical chemistry market in the coming years. A chronic disease is a condition that persists for a year or longer, requires ongoing medical attention, limits daily activities, or involves both factors. Chronic diseases such as diabetes, cancer, and cardiovascular disorders are among the leading causes of death and disability worldwide. Clinical chemistry supports the development and improvement of methods used to assess disease status and risk for various chronic conditions, including cardiovascular disease, diabetes, and hormonal disorders. It also provides essential laboratory support for public health initiatives related to influenza and specific infectious diseases. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal agency, approximately 194 million adults in the United States, representing 76.4% of the population, reported having at least one chronic condition in 2023. The prevalence was 59.5% among young adults, 78.4% among middle-aged adults, and 93% among older adults. Therefore, the rising burden of chronic diseases is contributing to the growth of the clinical chemistry market.
Major companies operating in the clinical chemistry market are increasingly focusing on launching advanced and user-friendly systems to gain a competitive advantage and improve laboratory efficiency. Innovations such as compact and automated analyzers are helping laboratories deliver high-quality diagnostics while streamlining workflows. For example, in July 2023, Siemens Healthineers, a Germany-based healthcare company, introduced the Atellica CI Analyzer, a compact testing system designed to address laboratory challenges related to diagnostic quality and operational efficiency. The analyzer incorporates advanced features including microvolume technology, an IMT sensor, and independent integration, which enhance test yield, ensure reliable results, and maintain high throughput. The Atellica CI Analyzer supports a broad and expanding menu of more than 200 assays across 20 disease areas, enabling result standardization and workflow optimization across laboratory networks.
In May 2024, Bruker Corporation, a US-based company specializing in the design, manufacture, and sale of scientific instruments and analytical and diagnostic solutions, acquired ELITechGroup for $954.6 million. This acquisition is intended to strengthen Bruker’s presence in the molecular diagnostics market, particularly within infectious disease diagnostics. By integrating ELITechGroup’s wide-ranging portfolio of molecular diagnostic systems, assays, and related technologies, Bruker aims to expand its infectious disease testing capabilities, including viral diagnostics that are increasingly important for modern healthcare. ELITechGroup is an Italy-based company that develops, manufactures, and markets a comprehensive range of diagnostic products, including instruments, reagents, and software solutions.
Major companies operating in the clinical chemistry market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., ELITechGroup SAS, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Siemens AG, Ortho Clinical Diagnostics Holdings plc, Diatron Mi Apac Private Limited, Nova Biomedical Corporation, Alfa Wassermann USA Inc., HORIBA Ltd., Mindray Medical International Limited, Randox Laboratories Limited, SYNLAB International GmbH, Agilent Technologies Inc., ARUP Laboratories Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Eurofins Scientific SE, GE Healthcare Technologies Ltd., Laboratory Corporation, Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Sysmex Corporation, Tosoh Corporation, Trinity Biotech plc, Waters Corporation, Werfen S.A.
North America was the largest region in the chemical chemistry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical chemistry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical chemistry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the clinical chemistry market by increasing costs of imported analyzers, precision sensors, optical components, reagents, and calibration materials used in laboratory testing systems. Hospitals and diagnostic laboratories in North America and Europe are most affected due to reliance on imported analytical instruments, while Asia-Pacific faces pricing pressure on reagent and consumable supply chains. These tariffs are raising operational costs and slowing equipment replacement cycles. However, they are also encouraging localized manufacturing of analyzers, regional reagent production, and strategic supplier diversification to enhance supply chain resilience.
The clinical chemistry market research report is one of a series of new reports that provides clinical chemistry market statistics, including clinical chemistry industry global market size, regional shares, competitors with a clinical chemistry market share, detailed clinical chemistry market segments, market trends and opportunities, and any further data you may need to thrive in the clinical chemistry industry. This clinical chemistry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Clinical chemistry is a field within medical laboratory sciences that involves the qualitative and quantitative examination of bodily fluids, mainly blood and urine, to diagnose and monitor diseases through the measurement of biochemical markers or analytes. It uses advanced analytical techniques to generate essential data that supports healthcare professionals in making accurate and informed clinical decisions.
The primary product types in clinical chemistry include analyzers, reagents, and consumables. An analyzer is a laboratory instrument used to measure the concentration of specific compounds in samples such as serum, plasma, urine, and other bodily fluids. These devices initiate chemical reactions using reagents, typically analyzing the serum portion obtained after centrifugation of blood or urine samples. Clinical chemistry applications include general chemistry tests, liver function tests, kidney function tests, urinalysis, electrolyte panels, lipid profiles, specialty chemical tests, and others. These tests are conducted across various healthcare settings, including hospitals, diagnostic and pathology laboratories, ambulatory surgery centers, and other end users.
The clinical chemistry market includes revenues earned by assays and analyzers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The clinical chemistry market size is expected to see strong growth in the next few years. It will grow to $23.57 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to growing demand for rapid diagnostic turnaround, rising adoption of decentralized testing models, expansion of personalized medicine diagnostics, increasing investments in automated laboratory solutions, higher focus on quality and compliance standards. Major trends in the forecast period include increasing adoption of fully automated chemistry analyzers, rising demand for high-throughput diagnostic testing, growing use of point-of-care chemistry systems, expansion of integrated analyzer-reagent platforms, enhanced focus on analytical accuracy and standardization.
The growing prevalence of chronic diseases is expected to drive the expansion of the clinical chemistry market in the coming years. A chronic disease is a condition that persists for a year or longer, requires ongoing medical attention, limits daily activities, or involves both factors. Chronic diseases such as diabetes, cancer, and cardiovascular disorders are among the leading causes of death and disability worldwide. Clinical chemistry supports the development and improvement of methods used to assess disease status and risk for various chronic conditions, including cardiovascular disease, diabetes, and hormonal disorders. It also provides essential laboratory support for public health initiatives related to influenza and specific infectious diseases. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal agency, approximately 194 million adults in the United States, representing 76.4% of the population, reported having at least one chronic condition in 2023. The prevalence was 59.5% among young adults, 78.4% among middle-aged adults, and 93% among older adults. Therefore, the rising burden of chronic diseases is contributing to the growth of the clinical chemistry market.
Major companies operating in the clinical chemistry market are increasingly focusing on launching advanced and user-friendly systems to gain a competitive advantage and improve laboratory efficiency. Innovations such as compact and automated analyzers are helping laboratories deliver high-quality diagnostics while streamlining workflows. For example, in July 2023, Siemens Healthineers, a Germany-based healthcare company, introduced the Atellica CI Analyzer, a compact testing system designed to address laboratory challenges related to diagnostic quality and operational efficiency. The analyzer incorporates advanced features including microvolume technology, an IMT sensor, and independent integration, which enhance test yield, ensure reliable results, and maintain high throughput. The Atellica CI Analyzer supports a broad and expanding menu of more than 200 assays across 20 disease areas, enabling result standardization and workflow optimization across laboratory networks.
In May 2024, Bruker Corporation, a US-based company specializing in the design, manufacture, and sale of scientific instruments and analytical and diagnostic solutions, acquired ELITechGroup for $954.6 million. This acquisition is intended to strengthen Bruker’s presence in the molecular diagnostics market, particularly within infectious disease diagnostics. By integrating ELITechGroup’s wide-ranging portfolio of molecular diagnostic systems, assays, and related technologies, Bruker aims to expand its infectious disease testing capabilities, including viral diagnostics that are increasingly important for modern healthcare. ELITechGroup is an Italy-based company that develops, manufactures, and markets a comprehensive range of diagnostic products, including instruments, reagents, and software solutions.
Major companies operating in the clinical chemistry market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., ELITechGroup SAS, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Siemens AG, Ortho Clinical Diagnostics Holdings plc, Diatron Mi Apac Private Limited, Nova Biomedical Corporation, Alfa Wassermann USA Inc., HORIBA Ltd., Mindray Medical International Limited, Randox Laboratories Limited, SYNLAB International GmbH, Agilent Technologies Inc., ARUP Laboratories Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Eurofins Scientific SE, GE Healthcare Technologies Ltd., Laboratory Corporation, Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Sysmex Corporation, Tosoh Corporation, Trinity Biotech plc, Waters Corporation, Werfen S.A.
North America was the largest region in the chemical chemistry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical chemistry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical chemistry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the clinical chemistry market by increasing costs of imported analyzers, precision sensors, optical components, reagents, and calibration materials used in laboratory testing systems. Hospitals and diagnostic laboratories in North America and Europe are most affected due to reliance on imported analytical instruments, while Asia-Pacific faces pricing pressure on reagent and consumable supply chains. These tariffs are raising operational costs and slowing equipment replacement cycles. However, they are also encouraging localized manufacturing of analyzers, regional reagent production, and strategic supplier diversification to enhance supply chain resilience.
The clinical chemistry market research report is one of a series of new reports that provides clinical chemistry market statistics, including clinical chemistry industry global market size, regional shares, competitors with a clinical chemistry market share, detailed clinical chemistry market segments, market trends and opportunities, and any further data you may need to thrive in the clinical chemistry industry. This clinical chemistry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Clinical chemistry is a field within medical laboratory sciences that involves the qualitative and quantitative examination of bodily fluids, mainly blood and urine, to diagnose and monitor diseases through the measurement of biochemical markers or analytes. It uses advanced analytical techniques to generate essential data that supports healthcare professionals in making accurate and informed clinical decisions.
The primary product types in clinical chemistry include analyzers, reagents, and consumables. An analyzer is a laboratory instrument used to measure the concentration of specific compounds in samples such as serum, plasma, urine, and other bodily fluids. These devices initiate chemical reactions using reagents, typically analyzing the serum portion obtained after centrifugation of blood or urine samples. Clinical chemistry applications include general chemistry tests, liver function tests, kidney function tests, urinalysis, electrolyte panels, lipid profiles, specialty chemical tests, and others. These tests are conducted across various healthcare settings, including hospitals, diagnostic and pathology laboratories, ambulatory surgery centers, and other end users.
The clinical chemistry market includes revenues earned by assays and analyzers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Clinical Chemistry Market Characteristics
3. Clinical Chemistry Market Supply Chain Analysis
4. Global Clinical Chemistry Market Trends and Strategies
5. Clinical Chemistry Market Analysis of End Use Industries
7. Global Clinical Chemistry Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Clinical Chemistry Total Addressable Market (TAM) Analysis for the Market
9. Clinical Chemistry Market Segmentation
10. Clinical Chemistry Market Regional and Country Analysis
11. Asia-Pacific Clinical Chemistry Market
12. China Clinical Chemistry Market
13. India Clinical Chemistry Market
14. Japan Clinical Chemistry Market
15. Australia Clinical Chemistry Market
16. Indonesia Clinical Chemistry Market
17. South Korea Clinical Chemistry Market
18. Taiwan Clinical Chemistry Market
19. South East Asia Clinical Chemistry Market
20. Western Europe Clinical Chemistry Market
21. UK Clinical Chemistry Market
22. Germany Clinical Chemistry Market
23. France Clinical Chemistry Market
24. Italy Clinical Chemistry Market
25. Spain Clinical Chemistry Market
26. Eastern Europe Clinical Chemistry Market
27. Russia Clinical Chemistry Market
28. North America Clinical Chemistry Market
29. USA Clinical Chemistry Market
30. Canada Clinical Chemistry Market
31. South America Clinical Chemistry Market
32. Brazil Clinical Chemistry Market
33. Middle East Clinical Chemistry Market
34. Africa Clinical Chemistry Market
36. Clinical Chemistry Market Competitive Landscape and Company Profiles
37. Clinical Chemistry Market Other Major and Innovative Companies
40. Clinical Chemistry Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Clinical Chemistry Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses clinical chemistry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for clinical chemistry? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical chemistry market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Analyzers; Reagents And Consumables2) By Application: General Chemistry Test; Liver Function Test; Kidney Function Test; Urinalysis; Electrolyte Panel; Lipid Profile; Specialty Chemical Test; Other Applications
3) By End User: Hospitals; Diagnostic Or Pathology Centers; Ambulatory Surgery Centers; Other End Users
Subsegments:
1) By Analyzers: Automated Clinical Chemistry Analyzers; Semi-Automated Clinical Chemistry Analyzers; Point-Of-Care (POC) Analyzers2) By Reagents And Consumables: Chemical Reagents; Enzymatic Reagents; Quality Control Materials; Calibration Standards
Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche Ltd.; ELITechGroup SAS; Beckman Coulter Inc.; Thermo Fisher Scientific Inc.; Siemens AG; Ortho Clinical Diagnostics Holdings plc; Diatron Mi Apac Private Limited; Nova Biomedical Corporation; Alfa Wassermann USA Inc.; HORIBA Ltd.; Mindray Medical International Limited; Randox Laboratories Limited; SYNLAB International GmbH; Agilent Technologies Inc.; ARUP Laboratories Inc.; Bio-Rad Laboratories Inc.; Bruker Corporation; Danaher Corporation; Eurofins Scientific SE; GE Healthcare Technologies Ltd.; Laboratory Corporation; Luminex Corporation; PerkinElmer Inc.; Quest Diagnostics Incorporated; Sysmex Corporation; Tosoh Corporation; Trinity Biotech plc; Waters Corporation; Werfen S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Clinical Chemistry market report include:- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- ELITechGroup SAS
- Beckman Coulter Inc.
- Thermo Fisher Scientific Inc.
- Siemens AG
- Ortho Clinical Diagnostics Holdings plc
- Diatron Mi Apac Private Limited
- Nova Biomedical Corporation
- Alfa Wassermann USA Inc.
- HORIBA Ltd.
- Mindray Medical International Limited
- Randox Laboratories Limited
- SYNLAB International GmbH
- Agilent Technologies Inc.
- ARUP Laboratories Inc.
- Bio-Rad Laboratories Inc.
- Bruker Corporation
- Danaher Corporation
- Eurofins Scientific SE
- GE Healthcare Technologies Ltd.
- Laboratory Corporation
- Luminex Corporation
- PerkinElmer Inc.
- Quest Diagnostics Incorporated
- Sysmex Corporation
- Tosoh Corporation
- Trinity Biotech plc
- Waters Corporation
- Werfen S.A.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 17.37 Billion |
| Forecasted Market Value ( USD | $ 23.57 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
